Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders [Yahoo! Finance]
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]